Back to ABT Stock Lookup

ABT Related Corporate News

May 21, 2013 08:02 AM Abbott (ABT) Receives CE Mark for XIENCE Coronary Stent System

Apr 18, 2013 08:04 AM Abbott Labs (ABT) REceives FDA Approval for TECNIS IOL

Apr 10, 2013 08:19 AM BG Medicine (BGMD) Affirms Receipt of CE Mark for Galectin-3 Assay (ABT)

Apr 10, 2013 08:05 AM Abbott (ABT) Receives CE Mark for ARCHITECT Galectin-3

Jan 2, 2013 07:57 AM Abbott (ABT) Completes Separation of AbbVie (ABBV)

Dec 20, 2012 05:22 PM Abbvie (ABBV) to Join S&P 500, Will Replace Fed. Investors (FII)

Dec 11, 2012 06:47 AM Sucampo (SCMP) unit Receives $15M Milestone from First AMITIZA Sale in Japan

Nov 28, 2012 05:42 PM Abbott (ABT) to Spin-Off AbbVie, Declares Special Dividend

Nov 26, 2012 06:48 AM Sucampo (SCMP), Abbott (ABT) Launch New Constipation Treatment in Japan

Nov 13, 2012 01:02 PM Abbott (ABT) Details Phase 3 Plans for DAA +/- Ribavirin on HCV

Nov 12, 2012 09:05 AM Bristol-Myers (BMY) Says Orencia Similar to Humira + MTX in PROs with RA

Nov 12, 2012 07:00 AM Abbott (ABT) Issues Encouraging Update on Phase 3 ABILITY-1 of HUMIRA

Nov 9, 2012 08:43 AM Abbott (ABT) Reports Results of Early Tender; Extends Expiration on Certain Issues

Nov 6, 2012 05:58 AM Abbott (ABT) Prices Aggregate $14.7B Senior Debt Offering

Oct 23, 2012 09:05 AM Seattle Genetics (SGEN) Expands ADC Collaboration w/ Abbott (ABT); Will Get $25M Upfront

Oct 22, 2012 11:03 AM Abbott (ABT) Updates on HUMIRA ULTRA 1, 2 on Active UC

Oct 15, 2012 10:12 AM Abbott Labs (ABT) Reports Encouraging Data from Aviator on HCV

Sep 6, 2012 08:21 AM Abbott (ABT) to Collaborate w/ Astellas Pharma Over TransVax Phase 3

Aug 28, 2012 07:32 AM Abbott (ABT) Receives CE Mark for Testosterone Assay

Aug 20, 2012 07:01 AM Abbott (ABT) Says XIENCE Xpedition Stent Receives CE Mark in Europe

Jul 13, 2012 09:04 AM Abbott (ABT) to Unveil New Data Management, Automation Features at AACC July 15-19

Jul 5, 2012 08:55 AM Sucampo (SCMP), Abbott (ABT) Get Approval for AMITIZA from Japan's MHLW

Jul 3, 2012 09:03 AM Abbott (ABT) Wins FDA Approval for Healon EndoCoat Protective Gel for Cataract Surgery

Jun 18, 2012 08:14 AM Abbott (ABT) Offers Results of Studies Evaluating LCIG, Says Safety Endpoint Showed AE Mild to Moderate

May 15, 2012 08:04 AM Abbott (ABT) XIENCE Stent Systems Get CE Mark in Europe

May 7, 2012 12:46 PM Abbott (ABT) Settles with U.S. Over Depakote; Will Pay ~$1.6B in Fines

May 7, 2012 12:31 PM Abbott Labs (ABT) Agrees to Pay $100M in 45-State Settlement

Apr 23, 2012 09:06 AM Abbott (ABT), St. Jude (STJ) Enter Product Promotion Agreement; Will Include FFR, Leads, ICD, and OCTs

Apr 19, 2012 09:50 AM Achillion (ACHN) Shares Slammed, Gilead (GILD), Idenix (IDIX) Rip on New HCV Treatment Data

Apr 19, 2012 07:14 AM Abbott (ABT), Enanta Report Positive Data from Co-Pilot in HCV Patients with First-Time Treatment

Apr 9, 2012 09:35 AM Abbott (ABT) Gets Japanese MHLW Approval for Next-Gen XIENCE PRIME Stent

Apr 4, 2012 10:39 AM Abbott (ABT) Shares Charge Higher as Investors Cheer Results of 'Co-Pilot' Study on ABT-450/r + ABT-333

Mar 28, 2012 04:19 PM Myriad (MYGN), Teva's Cephalon Enter BRCA Mutation Testing Agreement

Mar 21, 2012 09:39 AM Abbott (ABT) to Launch New Research-Based Pharma Company at End of FY12

Mar 19, 2012 08:57 AM Watson Pharma (WPI) Files ANDA with FDA for Generic NIASPAN

Mar 15, 2012 07:37 AM Abbott (ABT) Initiates Two Phase 3s for HUMIRA in Adults with HS

Mar 7, 2012 09:03 AM Abbott's (ABT) Absolute Pro Stent System Ges FDA Nod to Treat Iliac Artery Disease

Mar 6, 2012 09:02 AM Abbott (ABT), Merck (MRK) to Collaborate Over FISH-Based Diagnostic Test

Mar 2, 2012 09:36 AM Watson (WPI) Launches Generic Version of Abbott's PROMETRIUM

Feb 29, 2012 09:17 AM Abbott (ABT), Galapagos Enter $1.35B Development Agreement for RA Treatment GLPG0634

Feb 21, 2012 10:17 AM Supreme Court Rejects J&J's (JNJ) Request to Reinstate Ruling Against Abbott (ABT) -Bloomberg

Feb 17, 2012 07:58 AM Abbott (ABT) Receives Positive Opinion from CHMP on HUMIRA

Jan 30, 2012 06:16 AM DNDi, Abbott (ABT) Enter Tropical Disease Research Agreement

Jan 25, 2012 10:02 AM Abbott (ABT) Posts Strong Q4 Earnings, But Investors Eye Light Revs, Outlook

Jan 18, 2012 08:36 AM FDA WIll Install Abbott's (ABT) STARLIMS LIMS Technology in Testing Labs

Dec 28, 2011 07:01 AM Emergent (EBS) to Retain TRU-016 Rights Following Collaboration Termination w/ Abbott (ABT)

Dec 27, 2011 03:31 PM Mylan (MYL) Unit Launches First Generic Teveten Tabs

Dec 22, 2011 09:04 AM Abbott (ABT) Initiates ESPRIT I

Dec 12, 2011 06:06 AM Abbott (ABT), Reata Enter 2G AIM Development Collaboration; Abbot to Pay $400M License Fee

Dec 8, 2011 09:31 AM Abbott (ABT) Initiates Absorb BVS vs. XIENCE PRIME Evaluation Trial

Back to ABT Stock Lookup